Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

The complement system, neuronal injury, and cognitive function in horizontally-acquired HIV-infected youth.

McGuire JL, Gill AJ, Douglas SD, Kolson DL; CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2016 Dec;22(6):823-830. Epub 2016 Jun 6.

2.

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.

Morgan EE, Woods SP, Letendre SL, Franklin DR, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Ellis RJ, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I, Vaida F, Clifford DB; CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2013 Apr;19(2):150-6. doi: 10.1007/s13365-013-0152-3. Epub 2013 Feb 14.

3.

Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning.

Blackstone K, Moore DJ, Heaton RK, Franklin DR Jr, Woods SP, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Rivera-Mindt M, Deutsch R, Ellis RJ, Hampton Atkinson J, Grant I; CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group.

J Int Neuropsychol Soc. 2012 Jan;18(1):79-88. doi: 10.1017/S135561771100141X. Epub 2011 Nov 24.

Supplemental Content

Loading ...
Support Center